Difference between revisions of "Promethazine (Phenergan)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= First-generation antihistamine and dopamine receptor D2 antagonist. No known antineoplastic properties. Category:Drug index Category:Emesis preven...") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | =Mechanism of action= | + | ==Mechanism of action== |
First-generation antihistamine and dopamine receptor D2 antagonist. No known antineoplastic properties. | First-generation antihistamine and dopamine receptor D2 antagonist. No known antineoplastic properties. | ||
− | [[Category: | + | ==Also known as== |
+ | *'''Brand name:''' Phenergan | ||
+ | |||
+ | [[Category:Drugs]] | ||
+ | [[Category:Oral medications]] | ||
+ | [[Category:Rectal medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Dopamine receptor antagonist]] | [[Category:Dopamine receptor antagonist]] | ||
+ | [[Category:Phenothiazines]] | ||
− | [[Category: | + | [[Category:FDA approved in 1951]] |
Latest revision as of 19:32, 30 July 2018
Mechanism of action
First-generation antihistamine and dopamine receptor D2 antagonist. No known antineoplastic properties.
Also known as
- Brand name: Phenergan